Status:
COMPLETED
Progressive Resisted Exercise Plus Aerobic Exercise on Osteoporotic Systemic Lupus Erythmatosus
Lead Sponsor:
Cairo University
Conditions:
Systemic Lupus Erythematosus
Eligibility:
FEMALE
30-50 years
Phase:
NA
Brief Summary
systemic lupus erythematosus (SLE) is the most common autoimmune disease in women of childbearing age. Promoting physical activity is a major national priority for the general population, including pa...
Detailed Description
The following factors were found to be significantly related to lower BMD by univariate analysis: Caucasian race, older age at diagnosis, higher age at the time of the first DXA, longer disease durati...
Eligibility Criteria
Inclusion
- Diagnosis of systemic lupus erythematosus by the classification criteria ACRa and the 2019 EULARb/ACR Classification Criteria for systemic lupus erythematosus
- Systemic Lupus Erythematosus Disease Activity Index ≥4
- For 30 day prior, stable immunosuppressive therapy with steroid (0-20 mg/day) or other immunosuppressive medication such as hydroxychloroquine, chloroquine, azathioprine, methotrexate, mycophenolate mofetil, cyclosporine, belimumab, rituximab
Exclusion
- Those who are pregnant.
- Patients with active lupus nephritis, cardiovascular dysfunction, rhythm and conduction disorders.
- Patients with musculoskeletal disturbances; kidney and pulmonary involvements; peripheral neuropathy and fibromyalgia.
- Use of tobacco; treatment with lipid-lowering, chronotropic or antihypertensive drugs
Key Trial Info
Start Date :
May 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05392790
Start Date
May 23 2022
End Date
December 30 2023
Last Update
September 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nesma Morgan Allam
Tanta, Egypt